Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Roxane Tenta, Elizabeth Fragopoulou, Magafoula Tsoukala, Marianna Xanthopoulou, Maria Skyrianou, Harris Pratsinis & Dimitris Kletsas. (2017) Antiproliferative Effects of Red and White Wine Extracts in PC-3 Prostate Cancer Cells. Nutrition and Cancer 69:6, pages 952-961.
Read now
Read now
Spyros G Pneumaticos, Anthos Christofides, Eliona Gkioka, Theodoros Kalogeropoulos, Pavlos Msaouel & Michael Koutsilieris. (2013) Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications. Expert Opinion on Therapeutic Targets 17:12, pages 1395-1403.
Read now
Read now
Pavlos Msaouel, Gayathri Nandikolla, Spyros G Pneumaticos & Michael Koutsilieris. (2013) Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer. Expert Opinion on Investigational Drugs 22:11, pages 1385-1400.
Read now
Read now
Pavlos Msaouel, Evanthia Galanis & Michael Koutsilieris. (2009) Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology. Expert Opinion on Investigational Drugs 18:9, pages 1297-1316.
Read now
Read now
Iraklis C Mitsogiannis, Andreas Skolarikos & Charalambos Deliveliotis. (2009) Somatostatin analog lanreotide in the treatment of castration-resistant prostate cancer (CRPC). Expert Opinion on Pharmacotherapy 10:3, pages 493-501.
Read now
Read now
A Halapas, N Pissimissis, P Lembessis, I Rizos, AG Rigopoulos, DT Kremastinos & M Koutsilieris. (2008) Molecular diagnosis of the viral component in cardiomyopathies: pathophysiological, clinical and therapeutic implications. Expert Opinion on Therapeutic Targets 12:7, pages 821-836.
Read now
Read now
Pavlos Msaouel, Evanthia Diamanti, Marinela Tzanela & Michael Koutsilieris. (2007) Luteinising hormone-releasing hormone antagonists in prostate cancer therapy. Expert Opinion on Emerging Drugs 12:2, pages 285-299.
Read now
Read now
Michael Koutsilieris, John Bogdanos, Constantine Milathianakis, Peter Dimopoulos, Theodoros Dimopoulos, Dimitrios Karamanolakis, Antonis Halapas, Roxane Tenta, Haralampos Katopodis, Effie Papageorgiou, Nea Pitulis, Nikos Pissimissis, Peter Lembessis & Antigone Sourla. (2006) Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach. Expert Opinion on Investigational Drugs 15:7, pages 795-804.
Read now
Read now
Athanassios Tsintavis, Theocharis Lambou, John Vacalicos, Michael Koutsilieris, Dimitrios Karamanolakis, John Bogdanos, Constantine Milathianakis, Constantine Mitsiades & Theodoros Dimopoulos. (2002) Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer. Expert Opinion on Investigational Drugs 11:2, pages 283-293.
Read now
Read now
Articles from other publishers (30)
Mariana Santos-Pereira, Sara C. Pereira, Irene Rebelo, Maria A. Spadella, Pedro F. Oliveira & Marco G. Alves. (2023) Decoding the Influence of Obesity on Prostate Cancer and Its Transgenerational Impact. Nutrients 15:23, pages 4858.
Crossref
Crossref
Tzortzis NomikosKaterina GiotiMagafoula TsoukalaRoxane Tenta. (2021) Pumpkin Seed Extracts Inhibit Proliferation and Induce Autophagy in PC-3 Androgen Insensitive Prostate Cancer Cells. Journal of Medicinal Food.
Crossref
Crossref
Manni Wang, Fan Xia, Yuquan Wei & Xiawei Wei. (2020) Molecular mechanisms and clinical management of cancer bone metastasis. Bone Research 8:1.
Crossref
Crossref
Carlo Messina, Giulia Buzzatti, Chiara Dellepiane, Alessia Cavo, Francesco Tolomeo, Carlo Cattrini & Francesco Boccardo. (2016) Genitourinary tumours in the targeted therapies era. Anti-Cancer Drugs 27:10, pages 917-943.
Crossref
Crossref
Howard S. Smith & Robert L. Barkin. (2014) Painful Boney Metastases. American Journal of Therapeutics 21:2, pages 106-130.
Crossref
Crossref
Ioulia Evangelou, Constantina Petraki, Pavlos Msaouel, Andreas Scorilas, Eleni Sdrolia, Georgia Padazi, Vassilios Koborozos & Michael Koutsilieris. (2012) Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer. European Journal of Clinical Investigation 42:7, pages 777-783.
Crossref
Crossref
Chadi Nabhan, Timothy M. Lestingi, Angel Galvez, Kathy Tolzien, Susan K. Kelby, Dean Tsarwhas, Steven Newman & Jacob D. Bitran. (2009) Erlotinib Has Moderate Single-agent Activity in Chemotherapy-na?ve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial. Urology 74:3, pages 665-671.
Crossref
Crossref
Elena Theophanous, Constantina Petraki, Andreas Scorilas, Vassilios Komborozos, George Veloudis, Jozsef L. Varga, Marta Zarandi, Andrew V. Schally & Michael Koutsilieris. (2009) The Immunohistochemical Expression of Growth Hormone-Releasing Hormone Receptor Splice Variant 1 Is a Favorable Prognostic Marker in Colorectal Cancer. Molecular Medicine 15:7-8, pages 242-247.
Crossref
Crossref
Zacharoula Panteleakou, Peter Lembessis, Antigone Sourla, Nikolaos Pissimissis, Aristides Polyzos, Charalambos Deliveliotis & Michael Koutsilieris. (2009) Detection of Circulating Tumor Cells in Prostate Cancer Patients: Methodological Pitfalls and Clinical Relevance. Molecular Medicine 15:3-4, pages 101-114.
Crossref
Crossref
D. Schilling, G. Gakis, U. Bökeler, A. Stenzl, M.A. Kuczyk & A.S. Merseburger. (2009) Sekundäre Hormonablation beim hormonunabhängigen ProstatakarzinomSecondary hormonal ablation in hormone-independent prostate cancer. Der Urologe 48:2, pages 183-190.
Crossref
Crossref
Anastasia Stavropoulou & Antonios Halapas. (2009) . Molecular Medicine 15:5-6, pages 1.
Crossref
Crossref
G Haramis, Z Zhou, A Pyriochou, M Koutsilieris, C Roussos & A Papapetropoulos. (2008) cGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines. British Journal of Pharmacology 155:6, pages 804-813.
Crossref
Crossref
Xuenong Zou, Lijin Zou, Ying He & Cody Bünger. (2008) Molecular treatment strategies and surgical reconstruction for metastatic bone diseases. Cancer Treatment Reviews 34:6, pages 527-538.
Crossref
Crossref
Efstathia Papageorgiou, Nea Pitulis, Menelaos Manoussakis, Peter Lembessis & Michael Koutsilieris. (2008) Rosiglitazone Attenuates Insulin-Like Growth Factor 1 Receptor Survival Signaling in PC-3 Cells. Molecular Medicine 14:7-8, pages 403-411.
Crossref
Crossref
Pavlos Msaouel, Nikos Pissimissis, Antonios Halapas & Michael Koutsilieris. (2008) Mechanisms of bone metastasis in prostate cancer: clinical implications. Best Practice & Research Clinical Endocrinology & Metabolism 22:2, pages 341-355.
Crossref
Crossref
Constantine S. Mitsiades, Douglas W. McMillin, Steffen Klippel, Teru Hideshima, Dharminder Chauhan, Paul G. Richardson, Nikhil C. Munshi & Kenneth C. Anderson. (2007) The Role of the Bone Marrow Microenvironment in the Pathophysiology of Myeloma and Its Significance in the Development of More Effective Therapies. Hematology/Oncology Clinics of North America 21:6, pages 1007-1034.
Crossref
Crossref
Natalia D. Tararova, Natalya Narizhneva, Vadim Krivokrisenko, Andrei V. Gudkov & Katerina V. Gurova. (2007) Prostate cancer cells tolerate a narrow range of androgen receptor expression and activity. The Prostate 67:16, pages 1801-1815.
Crossref
Crossref
Michael Koutsilieris, Theodore Dimopoulos, Constantine Milathianakis, John Bogdanos, Dimitrios Karamanolakis, Nicholas Pissimissis, Antonis Halapas, Peter Lembessis, Andreas Papaioannou & Antigone Sourla. (2007) Combination of somatostatin analogues and dexamethasone (antisurvival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis. BJU International 100:s2 Prostate Can, pages 60-62.
Crossref
Crossref
Constantine S. Mitsiades, Nicholas S. Mitsiades, Paul G. Richardson, Nikhil C. Munshi & Kenneth C. Anderson. (2007) Multiple myeloma: A prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment. Journal of Cellular Biochemistry 101:4, pages 950-968.
Crossref
Crossref
Constantine S. Mitsiades, Nicholas S. Mitsiades, Nikhil C. Munshi, Paul G. Richardson & Kenneth C. Anderson. (2006) The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: Interplay of growth factors, their receptors and stromal interactions. European Journal of Cancer 42:11, pages 1564-1573.
Crossref
Crossref
M. Koutsilieris, R. Tenta, D. Tiblalexi, N. Pitulis, E. Sotiriou, P. Lembessis, J. Bogdanos, C. Milathianakis & A. Sourla. 2005. Integration/Interaction of Oncologic Growth. Integration/Interaction of Oncologic Growth
335
344
.
Brian Nicholson, Kathryn Gulding, Mark Conaway, Stephen R. Wedge & Dan Theodorescu. (2004) Combination Antiangiogenic and Androgen Deprivation Therapy for Prostate Cancer. Clinical Cancer Research 10:24, pages 8728-8734.
Crossref
Crossref
MARCO BISOFFI, IRENA KLIMA, EKATERINA GRESKO, PAUL N. DURFEE, WILLIAM C. HINES, JEFFREY K. GRIFFITH, URS E. STUDER & GEORGE N. THALMANN. (2004) EXPRESSION PROFILES OF ANDROGEN INDEPENDENT BONE METASTATIC PROSTATE CANCER CELLS INDICATE UP-REGULATION OF THE PUTATIVE SERINE-THREONINE KINASE GS3955. The Journal of Urology 172:3, pages 1145-1150.
Crossref
Crossref
Michael Koutsilieris, Constantine S. Mitsiades, John Bogdanos, Theodoros Dimopoulos, Dimitrios Karamanolakis, Constantine Milathianakis & Athanassios Tsintavis. (2004) Combination of Somatostatin Analog, Dexamethasone, and Standard Androgen Ablation Therapy in Stage D3 Prostate Cancer Patients with Bone Metastases. Clinical Cancer Research 10:13, pages 4398-4405.
Crossref
Crossref
Roxane Tenta, Despina Tiblalexi, Evangelia Sotiriou, Peter Lembessis, Menelaos Manoussakis & Michael Koutsilieris. (2003) Bone microenvironment‐related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC‐3 prostate cancer cells. The Prostate 59:2, pages 120-131.
Crossref
Crossref
Constantine S Mitsiades, Nicholas S Mitsiades, Ciaran J McMullan, Vassiliki Poulaki, Reshma Shringarpure, Masaharu Akiyama, Teru Hideshima, Dharminder Chauhan, Marie Joseph, Towia A Libermann, Carlos Garcı́a-Echeverrı́a, Mark A Pearson, Francesco Hofmann, Kenneth C Anderson & Andrew L Kung. (2004) Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. Cancer Cell 5:3, pages 221-230.
Crossref
Crossref
Carlo Vicentini, Claudio Festuccia, Giovanni Luca Gravina, Adriano Angelucci, Angelo Marronaro & Mauro Bologna. (2003) Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures. Journal of Cancer Research and Clinical Oncology 129:3, pages 165-174.
Crossref
Crossref
Dimitrios Karamanolakis, John Bogdanos, Antigone Sourla, Constantine Milathianakis, Athanassios Tsintavis, Peter Lembessis, Roxane Tenta, Despina Tiblalexi & Michael Koutsilieris. (2002) Molecular Evidence-Based Use of Bone Resorption-Targeted Therapy in Prostate Cancer Patients at High Risk for Bone Involvement. Molecular Medicine 8:11, pages 667-675.
Crossref
Crossref
J.-P. Droz, A. Fléchon & C. Terret. (2002) Prostate cancer: management of advanced disease. Annals of Oncology 13, pages 89-94.
Crossref
Crossref
Vassiliki Poulaki, Constantine S. Mitsiades, Vassiliki Kotoula, Sophia Tseleni-Balafouta, Avi Ashkenazi, Demetrios A. Koutras & Nicholas Mitsiades. (2002) Regulation of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Thyroid Carcinoma Cells. The American Journal of Pathology 161:2, pages 643-654.
Crossref
Crossref